The purpose of the Yale Cooperative Center of Excellence in Hematology is to enhance research in blood diseases by facilitating synergy between many different scientists both within Yale and at multiple academic institutions across the country.
The Center helps these scientists by providing access to and training in state-of-the-art technologies via 3 Technology Cores, Pilot and Feasibility Funding, and an Enrichment Program. Our unique focus is the application of emerging technologies to better understand blood diseases. The center plays a key role in the integrated program of blood disease research supported by other Cooperative Hematology Specialized Core Centers by providing opportunities to increase interactions and collaborations.
The Cell Preparation and Analysis Core provides essential and emerging technologies in hematology and relevant training for junior investigators, thus considerably increasing research efficiency, reducing expense, and saving valuable investigator time to achieve better advancement of hematologic research.
Hematopoiesis is a complex and dynamic process amenable to investigation using various imaging techniques. Yale is the home of many state-of-the-art imaging equipment and facilities overseen by world-renowned leaders and experts in microscopy. Establishment of the Imaging Core in the YCHSCC will make the large array of imaging platforms readily accessible to all investigators with a research interest in hematopoiesis, locally or nationally.
The Animal Modeling Core provides access to state of the art technologies for in vivo Hematology research. Specifically, this core provides access to immunodeficient mouse models for engraftment of primary human cells, and state of the art technologies to generate genetically modified mice, as well as teaching, expertise, and technical support for the study of hematopoiesis and hematologic questions in in vivo mouse models.